| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |